The company attributes this surge to sustained momentum in its e-commerce division and growing traction within its B2B sector. CEO Michael Edell noted that the firm is successfully expanding its recurring revenue base through higher subscription uptake, which has helped stabilize the company’s commercial model. These preliminary, unaudited figures signal a shift toward improved unit economics as earlier transition costs begin to taper off.
In section Releases
SenesTech Hits Record $1.1 Million Revenue Milestone
For the first time in its history, Surprise-based SenesTech has crossed the $1 million quarterly revenue threshold. The rodent control firm reported preliminary third-quarter earnings of $1.1 million, marking a 40% sequential increase over the second quarter and a 55% jump compared to the same period last year.
SenesTech, known for its fertility-based rodent management solutions like ContraPest and Evolve, plans to release its full, definitive financial results the week of November 9, 2026. While the current data remains subject to final closing procedures, leadership maintains that the business is effectively scaling its data-driven acquisition engines to prepare for long-term growth.
Comments (0)
No comments yet. Be the first!